The North America market for nuclear medicine is estimated at $1540 million in 2018 and is expected to reach $2609 million by 2024, growing at a CAGR of 11.5%. Nuclear medicine is a medical speciality involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine, in a sense, is “radiology did inside out” or “endoradiology” because it records radiation emitting from within the body rather than radiation that is generated by external sources like X-rays.
North America Nuclear Medicine Market Share:
The diagnostics segment holds the most significant share in nuclear medicine market in which again SPECT has the most significant percentage. In the segmentation based on type, the Beta Emitters contain the most significant share in North America Nuclear Medicine Market.
North America Nuclear Medicine Market Size:
On Basis of Geography, the Market has been segmented into the USA, Canada, and Mexico. Due to high technological advancement coupled with a developed economy, North America has the most significant market share globally. In North America, the USA holds the most significant market share. The nuclear medicine market is slated to grow in the US because of a higher
North America Nuclear Medicine Market Growth:
Increasing incidence of cancer, thyroidal diseases, endocrinal diseases, and cardiac ailments, Rise in applications of SPECT and PET with the advancement of technology, Growing awareness amongst physicians, Public awareness for better healthcare are the major factors that are driving the North America Nuclear medicine Market Growth.
North America Nuclear Medicine Market Industry Analysis:
The North American nuclear medicine market has been segmented based on type and application. The segmentation based on type of product has been further divided based on diagnostic market and therapeutic market, wherein, the diagnostics market has been further subdivided into SPECT radioisotopes that include Technetium-993, Thallium-201, Iodine-123, Gallium and PET radioisotopes that include Rubidium-82, Fluorine-18, and the therapeutics category has been segmented into Alpha emitters, Beta Emitters and Brachytherapy . The segmentation based on an application has been similarly subdivided based on diagnostic and therapeutic use. The diagnostic application includes the application of SPECT and PET in Cardiology, Neurology, Oncology and others. The therapeutic applications include application in Oncology, Thyroid, Endocrinology and various other therapeutic areas.
North America Nuclear Medicine Market Outlook:
North America’s market for nuclear medicine has ample opportunities in the form of Increasing imaging technologies, Potential radioisotopes in the pipeline, Increasing neurological applications, Increasing cyclotron-based production.
North America Nuclear Medicine Market Trends:
Nordion, Bruce Power and Cameco Companies work together to provide a reliable supply of Cobalt-60. IBA Group Company signed an agreement on cooperation of socially responsible organisations of Belarus in the implementation of CSR projects.
North America Nuclear Medicine Market Research report includes:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.